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The 50 untranslated region of the fragile Xmental retardation gene, FMR1, contains a polymorphic CGG repeat. Expansions of this repeat
are associated with a spectrum of disorders. Full mutation alleles, repeatsR 200, are associated with fragile X syndrome. Premutation
alleles, repeats of ~55–199, are associated with a tremor-ataxia syndrome most commonly in older males and primary ovarian insufﬁ-
ciency in females. However, the neuropsychological impact of carrying a premutation allele is presently unclear in younger adults. In
this study, we analyzed neuropsychological scores for 138males and 506 females ascertained from the general population and from fam-
ilies with a history of fragile X syndrome. Subjects were age 18–50 years and had varying repeat lengths. Neuropsychological scores were
obtained frommeasures of general intelligence, memory, and executive functioning, including attention. Principal component analysis
followed by varimax rotation was used to create independent factors for analysis. These factors were modeled for males and females
separately via a general linear model that accounted for correlation among related subjects. All models were adjusted for potential
confounders, including age at testing, ethnicity, and household income. Among males, no repeat length associations were detected
for any factor. Among females, only a signiﬁcant association with repeat length and self-report attention (p < 0.01) was detected,
with premutation carriers self-reporting signiﬁcantly more attention-related problems compared to noncarriers. No signiﬁcant interac-
tions between repeat length and age were detected. Overall, these results indicate the lack of a global neuropsychological impact of
carrying a premutation allele among adults under the age of 50.Introduction
The X-linked fragile X mental retardation gene, FMR1
(MIM 309550), contains a CGG repeat in the 50 untrans-
lated region.1 The most common alleles contain less than
40 repeats. In rare cases, this repeat can become unstable
and expand from one generation to the next.2 Expanded
alleles of FMR1 are associated with a spectrum of disorders.
Expansions of 200 repeats or more, termed full mutation
alleles, typically result in hypermethylation and subse-
quent silencing of FMR1.3–5 These alleles are associated
with fragile X mental retardation syndrome (FXS [MIM
300624]).6 Individuals with FXS present with a wide range
of phenotypic severity, including mild to severe intellec-
tual disabilities, with females typically more mildly
affected because of the X-linked nature of FMR1.
Alleles with repeats in the range of about 55–199, termed
premutation alleles, remain unmethylated and are thus
expressed. However, these alleles are associated with
increased levels of mRNA as well as decreased protein levels
as measured in blood.7–12 Roughly 20% of females who
carry premutation alleles have fragile X-associated primary
ovarian insufﬁciency (FXPOI).13–15 In addition, roughly
30% of males over the age of 50 who carry premutation
alleles will develop a tremor/ataxia disorder (FXTAS [MIM
300623]).16–18 FXTAS is characterized by a progressive in-
tention tremor and/or ataxia, cognitive deﬁcits, psychiatric
symptoms, and brain atrophy.16,18–22 Females who carry692 The American Journal of Human Genetics 83, 692–702, Decembpremutation alleles have also been reported with symp-
toms of FXTAS, but have reduced penetrance and possibly
a different presentation compared to males.23–27
The presence of additional phenotypes associated
with premutation alleles distinct from FXPOI or FXTAS is
unclear. Hunter et al.28 reviews past studies that report
neuropsychological phenotypes among carriers of premu-
tation alleles not affected by FXTAS. Many of these studies
were conducted prior to the characterization of FXTAS.
Thus, any phenotypes reported could be due to inclusion
of older carriers of premutation alleles with FXTAS. In addi-
tion, many studies are compromised by small samples
sizes, ascertainment biases associated with participant
recruitment, and the use of inappropriate control groups.
More recent published studies have overcome many of
these obstacles, but results still do not converge on a partic-
ular proﬁle.29–34
The goal of this study was to characterize neuropsycho-
logical phenotypes amongmale and female younger adults
who carry an FMR1 premutation allele in order to ask the
question: before the possible onset of FXTAS, what is the
neuropsychological impact of carrying a premutation
allele? The results of the study indicate a lack of a deﬁnitive
neuropsychological impact of the premutation allele
among both males and females. Given the notable
strengths of this study, including the recruitment of the
largest study population to date via strategies to reduce
potential participation biases, these results suggest that1Department of Human Genetics, 2Department of Psychology, Emory University School of Medicine, Atlanta, GA 30322, USA; 3Independent practice 1776
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Figure 1. Distribution of FMR1 CGG Repeat Lengths for All Male and Female Participantsthe FMR1 premutation allele probably acts as a quantitative
trait locus (QTL) in the sense that it may contribute a weak
effect on neuropsychological measures among young
adults, but by itself does not have a major gene effect.
Subjects and Methods
Study Population
Study participants were identiﬁed with two recruitment strategies.
First, subjects from the general population were recruited from
a variety of Atlanta area public sites such as churches, universities,
sports events, and health fairs. Second, in order to enrich the study
sample with carriers of expanded FMR1 alleles, participants were
recruited from families with a known history of FXS through
clinics, internet postings, FXS parent groups, and word of mouth.
Once a family was identiﬁed with FXS, all family members were
screened for the premutation and identiﬁed carriers and noncar-
riers were invited to participate. Participants were aged 18 to 50
years, had FMR1 alleles of less than 200 repeats (Figure 1), and
spoke English as their primary language. 506 women were ascer-
tained from 348 pedigrees and 138 men from 112 pedigrees. The
protocols and consent forms for ascertainment were approved
by the Institutional Review Board at Emory University.
Measurement of Neuropsychological Phenotypes
Study participants were asked to complete the eight neuropsycho-
logical tests listed in Table 1. This test battery was designed to as-
sess a broad range of abilities. 21 outcome scores from these tests
were used in this analysis (Table 1). Test administrators were blind
to each subject’s FMR1 genotype as well as family history of FXS.
The Conners’ Adult ADHD Rating Scales self-report long form
(CAARS-S:L) was used to assess symptoms associated with
ADHD.35 The CAARS consists of 66 items and provides an incon-
sistency index and 9 subscale scores: four factor-derived subscaleThe Americanscores, three DSM-IV ADHD symptom subscales, and an ADHD
index. The four factor-derived subscale scores are based on ADHD-
related symptoms and behaviors and were included in this analy-
sis. The ‘‘A’’ subscale assesses inattention and memory problems,
the ‘‘B’’ subscale assesses hyperactivity and restlessness, the ‘‘C’’
subscale assesses impulsivity and emotional lability, and the ‘‘D’’
subscale assesses problems with self-concept. Gender- and age-ad-
justed t scores were used for analysis. 12 (8.7%)men and 17 (3.4%)
women had missing scores for the CAARS. In addition, 8 (5.8%)
men and 29 (5.7%) women had inconsistency index scores of 8
or greater, which is indicative of potential inconsistency of the
responses. Therefore, these scores were removed from the analysis.
The Continuous Performance Test (CPT) was used to assess
sustained attention and vigilance.36 This computer-based task
requires the subject to detect infrequent targets and respond to
them by pressing the space bar whenever the same four-digit num-
ber appears in the screen twice in a row. Two types of test errors
were used in this analysis: omissions and commissions. Omis-
sions, or inattention errors, indicate the number of times the sub-
ject does not press the space bar after the appropriate stimulus and
reﬂects failures of sustained attention. Commissions (errors of im-
pulsivity or false alarm) indicate the number of times the subject
presses the space bar in the absence of the appropriate stimulus.
12 (8.7%) men and 41 (8.1%) women were missing scores for
the CPT.
The Controlled Oral Word Association Test (COWA-T) is a mea-
sure of verbal ﬂuency.37 The COWA-T is comprised of three parts
where subjects are asked to generate as many words as possible
that begin with the letters F, A, and S in three subsequent 60 s ses-
sions. The number of words provided in the three parts were added
and converted to age- and education-adjusted t scores. One (0.7%)
male was missing scores for the COWA-T.
The Stroop Color and Word Test (SCWT) is a sensorimotor
speed-efﬁciency task that measures the ability to suppress com-
mon responses, an aspect of executive functioning.38 The SCWT
consists of three subtests: the word test, the color test, and theJournal of Human Genetics 83, 692–702, December 12, 2008 693
Table 1. List of Neuropsychological Measures and 21 Outcome Variables Used in Analysis
Domain Test Name Outcome Variables
Attention Connors’ Adult ADHD Rating Scales (CAARS) 4 factor-derived subscales:
A t score: inattention/memory
B t score: hyperactivity/restlessness
C t score: impulsivity/emotional lability
D t score: problems with self-concept
Executive functioning Continuous Performance Test (CPT) number of omissions (OM); number of commissions (COM)
Controlled Oral Word Association Test (COWA-T) overall FAS t score (FAS)
Stroop Color and Word Test (SCWT) interference t score (INT)
Trail Making Test (TMT) part A: seconds to complete task
part B: seconds to complete task
Wisconsin Card Sorting Test (WCST) number of perseverative errors (PE)
Verbal memory Wechsler Memory Scale 3rd Edition (WMS-III) logical memory age-adjusted scaled scores:
immediate recall (LM1)
delayed recall (LM2)
delayed recognition (LM3)
Visual memory Wechsler Memory Scale 3rd Edition (WMS-III) Visual reproduction age-adjusted scaled scores:
immediate recall (VR1)
delayed recall (VR2)
Visual reproduction raw score:
delayed recognition (VR3)
General intelligence Wechsler Adult Intelligence Scale, 3rd Edition (WAIS-III) Factor index age-adjusted standard scores:
verbal comprehension (VCI)
perceptual organization (POI)
working memory (WMI)
processing speed (PSI)color-word test. The word test requires the subject to read color
names printed in black ink. The color test requires the subject to
name the color of the ink used to print the nonword string
‘‘XXXX.’’ The color-word test requires the subject to name the
color of the ink the words are printed in and not read the words.
Subjects are given 45 s to complete the task. The number of items
correctly completed from the three tasks is used to compute an
‘‘interference’’ score that reﬂects the ability to suppress the inter-
fering stimuli. Interference scores are converted to age-adjusted
t scores. Three (2.2%) men and two (0.4%) women had missing
scores for the SCWT.
The Trail Making Test (TMT) assesses visual scanning, attention,
and mental ﬂexibility.39 The task consists of two trials with differ-
ent complexities: part A involves visuomotor tracking of numbers
1 through 23 and part B involves the shifting of cognitive sets
while visuomotor tracking between numbers and letters. The
scores for parts A and B are the time in seconds used to complete
each task. One (0.7%) man was missing the TMT part A score,
two (1.4%) men were missing the TMT part B score, and three
(0.6%) women were missing scores for both TMT parts A and B.
The Wisconsin Card Sorting Test (WCST) assesses mental ﬂexi-
bility and the ability to adapt strategies to changing conditions.40
The WCST involves matching response cards to a set of stimulus
cards based on either the number of shapes on the card, the color
of the shapes, or the shapes themselves. However, the participant
is not told the sorting principal and is told only whether each
match was correct or incorrect. After a number of consecutive cor-
rect matches, the sorting principal changes and the participant
must shift to a new sorting strategy. In this analysis, the number
of perseverative errors was used as the outcome score. 6 (4.3%)
men and 24 (4.7%) women were missing scores for the WCST.
The Wechsler Memory Scale 3rd Edition (WMS-III) assesses
short- and long-term recall and recognition of verbal and visual in-
formation.41 The logical memory subtest involves recollection of694 The American Journal of Human Genetics 83, 692–702, Decembbrief stories and the visual reproduction subtest involves recollec-
tion of visual patterns. Logical memory and visual reproduction
subtest scores for immediate recall, delayed recall, and delayed rec-
ognition were used in this analysis. Raw scores are converted to
age-adjusted scaled scores for all scores except the logical memory
delayed recognition score. Two (1.4%) men were missing all scores
for visual reproduction as well as logical memory immediate and
delayed recall. Four (2.9%) men were missing scores for logical
memory delayed recall. Six (1.2%) women were missing scores
for visual reproduction immediate and delayed recall and logical
memory immediate recall. Seven (1.4%) women were missing
scores for logical memory delayed recall and delayed recognition.
Eight (1.6%) women were missing scores for visual reproduction
delayed recognition.
TheWechsler Adult Intelligence Scale 3rd Edition (WAIS-III) is an
intelligence battery that measures verbal and nonverbal cognitive
functioning.42 The battery provides four factor index scores that
capture the main themes or dimensions of the underlying perfor-
mance. The verbal comprehension index (VCI) is calculated with
three subtests (vocabulary, similarities, and information) andmea-
sures general verbal skills, such as verbal ﬂuency, ability to under-
stand and use verbal reasoning, and verbal knowledge. The percep-
tual organization index (POI) is calculated with three subtests
(picture completion, block design, and matrix reasoning) and as-
sesses the ability to examine a problem, draw upon visual-motor
and visual-spatial skills, organize thoughts, create solutions, and
then test them. The working memory index (WMI) is calculated
with three subtests (arithmetic, digit span, and letter-number se-
quencing) and assesses ability to memorize new information,
hold it in short-term memory, concentrate, and manipulate that
information to complete a task. The processing speed index (PSI)
is calculated with two subtests (digit symbol-coding and symbol
search) and assesses skills of focusing attention and quickly scan-
ning, discriminating between, and sequentially ordering visualer 12, 2008
information. All index scores were converted to age-adjusted
standard scores. One (0.7%) man was missing scores for VCI and
POI. Two (1.4%) men were missing scores for WMI and PSI. Six
(1.2%) women were missing scores for VCI, POI, WMI, and PSI.
The Wide Range Achievement Test 3 (WRAT-3) reading subscale
requires the participant to correctly pronounce a set of words while
reading them aloud. Raw scores from the reading subtest were con-
verted to age-standard scores and grade equivalents. Three (2.2%)
men and six (1.2%) women were missing WRAT-3 scores.
Laboratory Method
FMR1 CGG Repeat Number
All study participants were asked to provide a blood or buccal
brush sample for molecular analysis of FMR1 repeat length. DNA
was extracted from samples with the QIAGEN QiAmp DNA Blood
Mini Kit and analyzed with an ABI Prism 377 DNA ﬂuorescent-
sequencer.43 For males or females with a larger premutation allele
and for homozygous females, an alternative PCR-based, hybridiza-
tion technique was used.44 For heterozygous females, the CGG
repeat length from the larger repeat allele was used as the main
predictor in subsequent statistical analyses. For more information
on molecular analysis, see Allen et al.45
Statistical Analysis
Male and female participants were separated into three groups
based on their repeat length allele: noncarriers (%40 repeats),
intermediate allele carriers (41–60 repeats), and premutation allele
carriers (>60 repeats). To date, repeat length deﬁnitions with
respect to clinical application have been based on instability, not
on neuropsychological or neurobehavioral phenotype associa-
tions.46 Thus, we used the deﬁnitions outlined above to better bal-
ance sample sizes and to be consistent with previous studies.47,48
Table 2 lists demographic data stratiﬁed by gender and repeat
group. Repeat group differences for the demographic variables
shown were tested with analysis of variances for continuous vari-
ables and chi-square tests for dichotomous variables. Any variables
that differed across repeat groups would be included in models as
potential confounders. Categories for ethnicity, income, and edu-
cation were collapsed to create dichotomous variables. For the
male data set, the three repeat groups differed on ethnicity (%
white/Asian) (c2 ¼ 12.42, df ¼ 2, p < 0.01). For the female data
set, the three repeat groups differed on age (F ¼ 15.52, p < 0.01),
ethnicity (% white/Asian) (c2 ¼ 48.56, df ¼ 2, p < 0.01), and
household income (%R $50,000) (c2 ¼ 12.61, df ¼ 2, p < 0.01).
WRAT-3 reading scores across repeat groups were analyzed to ac-
count for potential confounding on test performance resulting
from possible learning disability. However, no differences in
reading abilities were detected for the male or female data set. In
addition, discrepancies between IQ and achievement scores, an
additional indicator of learning disability, were analyzed among
repeat groups. The mean differences between these scores as
well as the frequency of participants who had a difference
between scores greater than one standard deviation (discrepancy
scoreR 25) did not differ signiﬁcantly between repeat groups.
Unadjusted mean scores for the 21 outcome scores stratiﬁed by
gender and repeat length group are shown in Table 3. Distribu-
tions of all scores were tested for normality. Scores were trans-
formed, if necessary, to produce a normal distribution for further
analysis. A natural logarithm transformation was performed on
CPT omission and commission scores, TMT parts A and B scores,
and WCST perseverative error scores. Missing data points were
estimated with the EM algorithm.The AmericanIn order to further reduce the number of variables analyzed,
a principal component analysis (PCA) followed by varimax rota-
tion was used. Because the factor structure was not expected to
vary between males and females, the data from all participants
were used to create the new factors. The Kaiser-Meyer Olkin mea-
sure of sampling adequacy was 0.87. This was well above the cutoff
of 0.50 to indicate PCA is appropriate for these data because of the
signiﬁcant correlation among the 21 variables.49 Examination of
eigenvalues and scree plots suggested a model of six independent
factors based on the original 21 variables (Table 4). A cutoff value
of 0.40 for factor loadings was used for inclusion of a variable in
interpretation of each factor. This six-factor model accounted for
65.2% of the total variance of the original 21 variables (Table 4).
Because the new factor structure was obtained with data from all
participants, conﬁrmatory factor analysis was performed on the
male and female data sets separately to ensure the six-factor model
was a good ﬁt. Several measures were used to determine the ﬁt of
the six-factor structure, including the goodness of ﬁt index (GFI)
where a value of greater than 0.90 is indicative of a good ﬁt of
the model. The GFI values were 0.90 and 0.95 for the male and
female data sets, respectively.
Factor scores for all participants were computed for each partic-
ipant with the scoring coefﬁcients calculated by the PCA. The six
factor scores were analyzed as outcome variables via general linear
regression equations modeled for correlated outcomes. This
approach was used to adjust for correlated outcome values that
may have occurred among relatives from the same family because
of shared environmental or genetic factors. In addition, this
approach is robust to the varying family cluster sizes among our
sample population. The main predictor of these models was
FMR1 repeat length and was classiﬁed in two ways. First, repeat
length was used as a continuous variable to analyze linear associ-
ations between factor scores and repeat length. Second, repeat
length was used as a categorical variable to compare mean scores
across the three repeat groups: noncarriers, intermediate allele car-
riers, and premutation allele carriers. A Tukey’s post hoc analysis
was performed to test for adjusted factor mean score differences
among repeat length groups. In order to account for any potential
confounding, all models were adjusted for age, race, and income
(Table 2). All interaction terms between repeat variables and cova-
riates were tested for each model.
Lastly, to ensure that the imputation of missing data points did
not affect the factor structure or the results of the analyses, a
conﬁrmatory factor analysis was performed to test the ﬁt of the
six-factor model on the data set containing the missing data
points before imputation. In addition, the models analyzing
repeat length as a predictor of factor scores were repeated where
individual factor scores had been removed for participants that
were missing data for the speciﬁc measures used to interpret that
factor.
A simple Bonferonni correction was used to adjust for multiple
testing because the six new factors were uncorrelated. Thus a cutoff
value of p ¼ 0.01 was used to indicate signiﬁcance in these analy-
ses. All statistical analyses were performed with the PROC MI,
PROC PRINCOMP, PROC CALIS, and PROC MIXED procedures
on the SAS System for Windows, Release 9.1.
Results
Results from the models with FMR1 repeat length as a
continuous variable as the main predictor are shown inJournal of Human Genetics 83, 692–702, December 12, 2008 695
Table 2. Demographic Data of Study Male and Female Study Participants Stratified by FMR1 Repeat Length Group
Malesa Femalesb
Group All NC IM PM All NC IM PM
N 138 75 33 30 506 117 96 293
Age (in years)
Mean 35.9 36.6 33.4 36.8 35.3 33.3 31.9 37.2
SD 9.3 8.8 10.2 9.2 9.4 9.8 11.1 8.1
Range 18–50 20–50 18–50 18–50 18–50 18–50 18–50 18–50
ANOVA:
F¼1.58,
p¼0.21
ANOVA:
F¼15.52,
p<0.01
Ethnicity
% white 78.8 82.4 57.6 93.3 76.3 61.2 59.4 88.5
% Asian 0.0 0.0 0.0 0.0 0.8 2.6 1.0 0.0
% African American 17.5 13.5 39.4 3.3 17.6 30.2 34.4 6.5
% Hispanic 2.2 2.7 0.0 3.3 3.5 4.3 1.0 4.0
% other 1.5 1.4 3.0 0.0 1.8 1.7 4.2 1.1
c2¼12.42,
df¼2,
p<0.01
c2¼48.56,
df¼2,
p<0.01
Education
% HS/GED not completed 0.7 0.0 3.0 0.0 0.2 0.0 0.0 0.3
% HS/GED completed 15.2 12.0 12.1 26.7 10.9 7.7 8.3 13.0
% trade/vocational school 4.4 2.7 6.1 6.7 3.6 1.7 4.2 4.1
% college not completed 38.4 42.7 42.4 23.3 36.8 38.5 51.0 31.4
% college completed 27.5 30.7 21.2 26.7 33.4 33.3 30.2 34.5
% graduate/professional school 13.8 12.0 15.2 16.7 15.2 18.8 6.3 16.7
c2¼4.64,
df¼2,
p¼0.10
c2¼4.72,
df¼2,
p¼0.10
Household Income
% <$10,000 1.5 1.4 3.2 0.0 3.7 2.6 8.7 2.5
% $10–25,000 7.7 8.5 9.7 3.6 8.6 14.0 9.8 6.0
% $25–50,000 20.0 16.9 22.6 25.0 24.7 23.7 32.6 22.6
% $50–75,000 25.4 22.5 29.0 28.6 22.7 27.2 19.6 21.9
% $75–100,000 16.9 15.5 22.6 14.3 20.3 14.0 14.1 24.7
% >$100,000 28.5 35.2 12.9 28.6 20.0 18.4 15.2 22.3
c2¼0.80,
df¼2,
p¼0.67
c2¼12.61,
df¼2,
p<0.01
WRAT-3
Mean 102.3 102.8 102.1 101.0 102.2 104.2 101.9 101.6
SD 11.6 9.8 15.4 11.6 10.7 9.8 12.6 10.2
Range 63–121 77–120 63–121 75–119 51–122 70–121 65–122 51–121
ANOVA:
F¼0.26,
p¼0.77
ANOVA:
F¼2.61,
p¼0.07
Abbreviations: NC, noncarriers; IM, intermediate allele carriers; PM, premutation allele carriers; SD, standard deviation; HS, high school; GED, General
Education Development; WRAT-3, Wide Range Achievement Test 3.
a Among male participants: 1 missing race, 8 missing income, and 3 missing WRAT scores.
b Among female participants: 16 missing race, 17 missing income, and 6 missing WRAT scores.Table 5. For both the male and female data sets, repeat
length as a continuous variable was not a statistically sig-
niﬁcant predictor for any of the six factor scores with the
Bonferonni correction for multiple testing (i.e., p < 0.01).
For the female data set, repeat length was marginally statis-696 The American Journal of Human Genetics 83, 692–702, Decembtically signiﬁcant as a predictor for processing speed (factor
3, p ¼ 0.05) and self-reported inattention and impulsivity
(factor 4, p ¼ 0.02) (Table 5). Both models indicated posi-
tive linear associations between repeat length and these
two factor scores, indicative of reduced processing speeder 12, 2008
and higher levels of symptoms associated with self-
reported ADHD.
For the models where repeat length as a categorical vari-
able was used as the main predictor, adjusted mean scores
for the three repeat classes and associated p values are
shown in Table 6. For the male data set, repeat length
was not a statistically signiﬁcant predictor of any of the
factors scores. In addition, with Tukey’s post hoc analysis
to compare the adjusted group means, factor scores did
not differ signiﬁcantly among repeat groups. For the
Table 3. Unadjusted Mean Scores on Neuropsychological Measures by Gender and Repeat Group
Neuropsychological Outcome Measures
Males Females
N All NC IM PM N All NC IM PM
CAARS A 118 47.9 47.0 50.0 48.0 460 49.9 47.7 48.8 51.1
B 118 50.4 49.5 50.5 52.8 460 49.5 49.1 49.1 49.8
C 118 45.1 45.0 44.7 45.8 460 46.6 43.8 45.2 48.1
D 118 45.8 45.2 47.3 45.7 460 46.4 44.0 44.7 47.8
CPT OM 126 5.7 4.9 6.0 7.5 465 5.3 5.8 5.9 4.9
COM 126 9.0 10.7 6.5 7.0 465 8.0 7.1 10.6 7.5
COWA-T FAS 137 46.5 47.0 46.6 45.3 506 47.1 47.7 47.1 46.9
SCWT INT 135 51.5 52.1 50.5 51.2 504 51.2 50.5 50.8 51.5
TMT A 137 23.2 23.1 24.2 22.5 503 22.0 21.4 21.9 22.2
B 136 55.3 54.4 55.0 57.8 503 52.4 54.3 53.4 51.3
WCST PE 132 9.3 9.5 8.1 10.4 482 9.3 8.0 10.2 9.5
WMS-III LM1 136 10.5 10.6 10.3 10.6 500 11.3 11.2 10.7 11.6
LM2 136 10.9 10.9 10.8 11.1 499 11.9 11.8 11.4 12.1
LM3 134 26.3 26.2 26.3 26.4 499 27.0 27.0 26.9 27.0
VR1 136 9.0 8.7 9.4 9.3 500 8.8 8.8 8.6 8.8
VR2 136 10.7 10.6 11.3 10.4 500 10.4 10.7 10.4 10.4
VR3 136 11.5 11.4 11.5 11.4 498 11.0 11.1 10.8 10.9
WAIS-III VCI 137 109.8 109.8 110.8 108.8 500 106.3 109.4 106.6 105.1
POI 137 113.5 113.5 112.0 115.3 500 109.1 108.3 107.1 110.2
WMI 136 105.2 105.7 103.1 106.4 500 102.5 103.1 102.0 102.4
PSI 136 101.4 101.5 102.2 100.1 500 108.3 108.3 106.5 109.0
Table 4. Structure of Six Factors Derived from Principal Component Analysis with Varimax Rotation and Associated Factor
Loadings that Represent Correlations between the New Factors and the Original Neuropsychological Measures from Both Male
and Female Participants
Factor 1 2 3 4 5 6
Factor Interpretation
Visual Processing
and Memory
Verbal Comprehension
and Memory
Processing
Speed
Self-Report Inattention
and Impulsivity
Sustained
Attention
Response
Fluency
CAARS A 0.04 0.00 0.16 0.82 0.02 0.01
B 0.07 0.14 0.08 0.71 0.03 0.06
C 0.00 0.03 0.05 0.82 0.12 0.01
D 0.05 0.09 0.14 0.73 0.03 0.09
CPT OM 0.06 0.10 0.19 0.00 0.79 0.08
COM 0.20 0.16 0.08 0.10 0.75 0.19
COWA-T FAS 0.03 0.30 0.42 0.03 0.10 0.45
SCWT INT 0.16 0.05 0.08 0.05 0.08 0.79
TMT A 0.18 0.04 0.79 0.15 0.00 0.01
B 0.21 0.17 0.76 0.00 0.22 0.13
WCST PE 0.31 0.09 0.30 0.03 0.44 0.18
WMS-III LM1 0.16 0.87 0.16 0.02 0.17 0.06
LM2 0.17 0.89 0.08 0.01 0.15 0.06
LM3 0.13 0.80 0.17 0.06 0.02 0.05
VR1 0.82 0.20 0.09 0.05 0.04 0.06
VR2 0.80 0.14 0.11 0.04 0.08 0.12
VR3 0.76 0.08 0.19 0.04 0.16 0.03
WAIS-III VCI 0.39 0.45 0.23 0.01 0.09 0.37
POI 0.61 0.12 0.37 0.06 0.22 0.21
WMI 0.32 0.29 0.47 0.01 0.23 0.34
PSI 0.15 0.20 0.71 0.07 0.22 0.12
% of variance explained 29.7 11.5 8.1 6.6 5.0 4.3
Factors loadings >0.40 (shown in bold) were used to interpret the new factors.The American Journal of Human Genetics 83, 692–702, December 12, 2008 697
female data set, repeat length was a marginally statistically
signiﬁcant predictor for self-reported inattention and
impulsivity (factor 4, p ¼ 0.01) (Table 6). With the Tukey’s
post hoc analysis, the adjusted mean scores for this factor
were signiﬁcantly higher for the premutation group com-
pared to the noncarrier group (p < 0.01). These results
indicate increased severity of self-reported symptoms
associated with inattention and impulsivity.
As shown in Table 4, the inattention and impulsivity
factor (factor 4) is heavily loaded by the four CAARS sub-
scale scores that assess symptoms associated with ADHD.
In order to follow up the above results ofmore severe symp-
toms among females with the premutation, adjusted mean
scores for the four CAARS subscales were compared among
females for the three repeat groups. Results are shown in
Table 7. The premutation group scored marginally signiﬁ-
cantly higher than did noncarriers for inattention and
memory, impulsivity and emotional lability, and problems
with self-concept, but not for hyperactivity and restless-
ness.
In order to assess what these results might indicate
clinically, the frequency of female participants who had
aCAARS subscale t score of 65or greaterwas analyzed across
repeat groups,where a t score of 65 or greater is indicative of
elevated symptoms.35 We used generalized estimating
equation (GEE) models to analyze this frequency across re-
peat groupswhile adjusting for covariates. Thepremutation
group did not differ signiﬁcantly from the noncarrier group
for the frequency of scoring above this clinical signiﬁcant
cut-off value for the CAARS subscale A (OR ¼ 3.31; 95%
CI 0.86 to 12.71; p ¼ 0.08), B (OR ¼ 1.19; 95% CI 0.42 to
3.37; p ¼ 0.74), C (OR ¼ 4.59; 95% CI 0.85 to 24.65; p ¼
0.08), or D (OR ¼ 2.76; 95% CI 0.74 to 10.33; p ¼ 0.13).
However, the point estimates of theORswere>1 for all sub-
scales with the highest point estimates for inattention and
memory, impulsivity and emotional lability, and problems
with self-concept, similar to the results above.
Anyphenotypesdetected among femaleswhocarry apre-
mutation allele could potentially bedue to thepsychosocial
Table 5. Results from the General Linear Model with FMR1
Repeat Length as the Main Predictor
Gender Factor
Standardized
b Estimates p Value
Males 1: Visual processing and memory 0.05 0.52
2: Verbal comprehension and memory 0.03 0.75
3: Processing speed 0.03 0.78
4: Self-report inattention
and impulsivity
0.06 0.42
5: Sustained attention 0.10 0.15
6: Response fluency 0.01 0.84
Females 1: Visual processing and memory 0.09 0.08
2: Verbal comprehension and memory <0.01 0.96
3: Processing speed 0.10 0.05
4: Self-report inattention
and impulsivity
0.11 0.02
5: Sustained attention 0.02 0.71
6: Response fluency 0.02 0.60698 The American Journal of Human Genetics 83, 692–702, Decembstress of raising a child with FXS. Therefore, in a follow-up
analysis, a new covariate was added to the ADHD models
for females to indicate whether or not the participant was
a mother of a child with FXS. Among the female partici-
pants who carried a premutation allele, 162 were mothers
of a child with FXS and 103 were known to not have a child
with FXS.However, for the linearmodelswith repeat length
as a continuous variable, this covariate was not a signiﬁcant
predictor of factor 4 scores (p ¼ 0.48) or the CAARS ADHD
subscores A (p ¼ 0.16), B (p ¼ 0.73), C (p ¼ 0.21), or D
(p¼0.95). This covariatewas alsonot a signiﬁcant predictor
in the models with repeat length as a categorical model for
factor 4 scores (p ¼ 0.31) or the CAARS subscores A (p ¼
0.56), B (p¼ 0.36), C (p¼ 0.13), orD (p¼ 0.78). In addition,
among female carriers of premutations,mean scores didnot
differ between thosewith andwithout childrenwith fragile
X for factor 4 (p¼0.34) or theCAARS subscoresA (p¼0.61),
B (p ¼ 0.39), C (p ¼ 0.16), or D (p ¼ 0.79).
In addition, a nonlinear association or ‘‘threshold’’ effect
between repeat length and factors scores is possible. Car-
riers with R100 repeats could be more likely to manifest
neuropsychological symptoms given the signiﬁcantly
increased levels of FMR1 transcript and, importantly, the
decreased levels of FMRP in this repeat range.8,10,50 There-
fore, in a second follow-up analysis, premutation carriers
with repeatsR100 were compared to noncarriers (%40 re-
peats) in models of all six factor scores. In the male sample,
10 of the 30 premutation carriers had repeatsR100 and, in
the female sample, 70 of the 293 premutation carriers had
repeats R100. The premutation group with R100 repeats
did not score signiﬁcantly different compared to the
noncarrier group (repeats % 40) for any of the six factors
among the male data set (p values of 0.18, 0.75, 0.43,
Table 6. Results from the General Linear Model Results via
Indicator Variables to Compare FMR1 Repeat Length Groups as
the Main Predictors
Gender Factor
Adjusted Group Means
p ValueNC IM PM
Males 1: Visual processing
and memory
0.16 0.50 0.20 0.36
2: Verbal comprehension
and memory
0.32 0.30 0.29 0.99
3: Processing speed 0.19 0.25 0.31 0.83
4: Self-report inattention
and impulsivity
0.10 0.05 0.02 0.69
5: Sustained attention 0.10 0.03 0.13 0.51
6: Response fluency 0.24 0.28 0.11 0.74
Females 1: Visual processing
and memory
0.04 0.00 0.13 0.33
2: Verbal comprehension
and memory
0.10 0.02 0.12 0.57
3: Processing speed 0.10 0.12 0.03 0.74
4: Self-report inattention
and impulsivity
0.20a 0.03 0.17a 0.01
5: Sustained attention 0.01 0.11 0.07 0.42
6: Response fluency 0.05 0.04 0.10 0.88
a Mean factor scores significantly different (p < 0.01).er 12, 2008
Table 7. Analysis of Individual CAARS Scores to Follow Up on Mean Factor 4 Score Differences between Female Noncarrier and
Premutation Carrier Groups
CAARS Subscale Symptoms Assessed
Adjusted Group Means
p ValueNC IM PM
A inattention and memory 47.90a 49.36 51.18a 0.02
B hyperactivity and restlessness 49.03 49.43 49.84 0.72
C impulsivity and emotional lability 44.23a 45.77 47.95a 0.02
D problems with self-concept 44.73b 45.75 47.58b 0.05
a Mean factor scores marginally significantly different (p ¼ 0.01).
b Mean factor scores marginally significantly different (p ¼ 0.02).0.77, 0.24, and 0.67, respectively) or among the female
data set (p values of 0.05, 0.37, 0.03, 0.04, 0.95, and
0.08, respectively).
Tests of all interaction terms between the covariates and
FMR1 repeat length variables, both continuous and cate-
gorical, were not signiﬁcant. This indicates that none of
the covariates, including age, modify the effect of repeat
length on neuropsychological scores.
Finally, a conﬁrmatory factor analysis indicated that the
six-factor model obtained from the data set with imputa-
tion of missing values was a good ﬁt for the data set with
missing data points (GFI ¼ 0.95). In addition, models run
withmissing factor scoreswhere the original outcome score
which loaded onto a particular factor provided similar pat-
terns of signiﬁcant associations between repeat length and
factor scores.Noneof the factormodels for themale data set
reached signiﬁcance, whereas among the female data set,
three models reached marginal signiﬁcance: models with
repeat length as a continuous variable as a predictor of fac-
tor 3 (p ¼ 0.03) and factor 4 (p ¼ 0.03) and the model with
repeat length as a categorical variable as a predictor of factor
4 (p¼ 0.02). Thus, there is no evidence that the imputation
of missing data altered the analyses.
Discussion
The purpose of this study was to investigate potential
effects of FMR1 premutation alleles on neuropsychological
performance among younger adult males and females.
The presence of a neuropsychological phenotype in the
absence of FXTAS or perhaps before the onset of FXTAS is
presently unclear. Recruitment strategies utilized in this
study have successfully limited potential ascertainment
biases while attaining the largest study population to date.
All participants were administered a neuropsychological
test battery that included assessments of attention, execu-
tive functioning, visual and verbal memory, and general
intelligence. The 21 primary outcome scores derived from
the eight neuropsychological tests were used in a principal
component analysis to construct a six-factor model (Ta-
ble 4). Factor loadings of the original 21 variables were
used to interpret the new factors: visual processing and
memory, verbal comprehension and memory, processingThe Americanspeed, self-report inattention and impulsivity, sustained
attention, and response ﬂuency (Table 4).
Overall, there was no statistically signiﬁcant association
of the six neuropsychological factor scores with FMR1
repeat length in the male data set, deﬁned either as a con-
tinuous variable or by repeat size class, after adjustment for
multiple testing. This was true also for the female data set,
with the exception of one marginally signiﬁcant ﬁnding
that was further explored.
Our data suggested that females with the premutation re-
ported signiﬁcantly more severe symptoms associated with
ADHD than did noncarriers. This was reﬂected by the posi-
tive associationof repeat lengthwith factor 4,whichwas in-
terpreted as self-reported inattention and impulsivity. In
addition, the premutation group had a signiﬁcantly higher
mean factor 4 score than did the noncarrier group. Factor 4
washeavily loadedby the four subscale scores of theCAARS.
Post-hoc analyses suggested that femaleswith the premuta-
tion scoredhigher thannoncarriers on theCAARS subscales
that assessed inattention and memory, impulsivity and
emotional lability, and problems with self-concept, but
not hyperactivity and restlessness. However, it is important
to note that because a t score of 65 or higher is indicative of
elevated symptoms,35 the mean scores of all repeat groups
are in the normal range, including the premutation group.
In addition, the frequency of participantswho scored above
this cutoff value did not statistically differ across repeat
groups for any of the CAARS subscores. Therefore, these
results suggest that females with the premutation may be
at risk for increased severity of some symptoms associated
with ADHD, but not necessarily the presence of clinical
ADHD. The elevated mean score for problems with self-
concept among female carriers of premutation alleles is
consistent with our ﬁndings in a recent study on this
population, where scores for general negative affect were
elevated in premutation carriers.48
Based on the fact that the FMR1 gene is located on the X
chromosome, a more severe phenotype among male car-
riers would be expected. However, this pattern was not
evident for the symptoms related to ADHD. One explana-
tion could be that these phenotypes are not due directly to
FMR1 repeat length, but instead to the psychosocial stress
of raising a child with FXS. However, tests of a covariate
representing raising a child with FXS was not a signiﬁcantJournal of Human Genetics 83, 692–702, December 12, 2008 699
predictor of ADHD scores among the female data set.
Another explanation could be that because the CAARS is
a self-report questionnaire, women report the symptoms
associated with ADHD differently than do men. A third
explanation could be that the increased sample size among
females compared with males allowed for greater power to
detect smaller differences.
Previous studies have suggested that individuals with
R100 repeats may be more like to manifest symptoms
related to the mutation because increased levels of FMR1
transcript as well as decreased levels of FMRP are evi-
dent.8,10,50 In our exploratory analyses on a subset of indi-
viduals with these large repeats, we found no evidence for
neuropsychological impairment.
Comparison of our results to themost recently published
studies is encouraging.29–31 Cornish et al.30 and Grigsby
et al. 31 are the largest of these recently published studies ex-
amining neuropsychological functioning among premuta-
tion males without FXTAS. Overall, the major ﬁndings of
these two studies are similar to ours: most neuropsycholog-
ical measures that were administered were not signiﬁcantly
different among adult carriers without FXTAS and noncar-
riers. Cornish et al. 30 found no differences among carriers
andnoncarriers under the age of 50 for general intelligence,
sustained attention, visual spatial function, or visual mem-
ory function. Similarly, Grigsby et al. 31 found no differ-
ences amongpremutation carrierswithout FXTAS andnon-
carriers in general intelligence, working memory, remote
recall of information, verbal learning, language, informa-
tion processing, visual-spatial functioning, or temporal se-
quencing. Both studies did ﬁnd executive function deﬁcits
among premutation carriers, a phenotype that we did not
observe. For example, Cornish et al. 30 found a signiﬁcant
deﬁcit in response inhibition, a component of executive
function, among men under age 50. Grigsby et al. 31 found
that carriers without FXTAS performed worse than noncar-
riers on executive cognitive functioning and some aspects
of verbal learning and memory.
There are several possible explanations for these differ-
ing results. First, the age distribution of participants varied
across studies. This is important because Cornish et al. 30
found that the difference between carriers and noncarriers
for response inhibition deﬁcits increased with increasing
age. Second, the repeat length distribution in each sample
may differ. Although we found no association with repeat
length, even among those with the highest repeats, other
studies may have a larger proportion of carriers with
R100 repeat alleles, increasing the power of detecting
small effect sizes. Third, the neuropsychological measures
and the use of composite scores differed across studies;
one measure may have a higher probability of tapping
into a speciﬁc domain than another. Fourth, the variability
in results could be due to different sizes of study popula-
tions and recruitment strategies. Lastly, all studies con-
ducted many statistical tests and signiﬁcant differences
could be due to chance, particularly if the study does not
adjust for multiple testing.700 The American Journal of Human Genetics 83, 692–702, DecembThere are some potential limitations to our study. First,
though the neuropsychological testers were blind to the
FMR1 repeat length status of the participants and partici-
pants are asked to not disclose this status to testers, the
participants typically knew their status prior to testing,
particularly those recruited from families with a history
of FXS. This could impact how these participants respond
to the self-report questionnaires, particularly those assess-
ing self-concept. McConkie-Rosell et al. reported decreased
feelings of self-concept among carriers compared to non-
carriers after learning about carrier status.51 This could
explain the results in this study regarding the increased
CAARS subscores for problems with self-concept, but not
the increased CAARS subscores for inattention and mem-
ory and impulsivity and emotional lability. Further, it is
possible that carriers familiar with recent literature citing
neuropsychological and neurobehavioral deﬁcits among
carriers without FXTAS might be biased in their responses
to the self-report questionnaires. Second, though every
effort was made to limit ascertainment biases, there is the
potential that those that agree to participate and complete
the neuropsychological test battery might be less likely to
have cognitive deﬁcits or inattention issues. However,
this would be true for both carrier and noncarrier recruits.
Despite these potential limitations, the results of this
study are encouraging. Given the large study population,
particularly for females, and the limited ascertainment
biases associated with recruitment, the lack of performance
differences on neuropsychological assessments between
carriers and noncarriers ismonumental in the study of frag-
ile X-associated phenotypes. These results indicate that in
the absence of FXTAS, there is no global neuropsychological
impactof carryingapremutationallele, at least among those
<50 years of age. Importantly, these results are consistent
with the larger, recent studies that have tried to overcome
study design problems. These ﬁndings are clinically impor-
tant to families with fragile-X spectrum disorders. On aver-
age, young adults, and by inference, children who carry
the permutation, should be assured that the premutation
form of the FMR1 gene is only one of many genes that con-
tribute to their neuropsychological strengths and hurdles.
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